These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
529 related items for PubMed ID: 22085136
1. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans. Aslan D, Andersen MD, Gede LB, de Franca TK, Jørgensen SR, Schwarz P, Jørgensen NR. Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136 [Abstract] [Full Text] [Related]
2. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics. Lombardi G, Di Somma C, Rubino M, Faggiano A, Vuolo L, Guerra E, Contaldi P, Savastano S, Colao A. J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975 [Abstract] [Full Text] [Related]
4. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone]. Kobayashi T. Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985 [Abstract] [Full Text] [Related]
5. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Goltzman D. Arch Biochem Biophys; 2008 May 15; 473(2):218-24. PubMed ID: 18358824 [Abstract] [Full Text] [Related]
6. Parathyroid hormone - a bone anabolic and catabolic agent. Poole KE, Reeve J. Curr Opin Pharmacol; 2005 Dec 15; 5(6):612-7. PubMed ID: 16181808 [Abstract] [Full Text] [Related]
7. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone. Schneider MR, Dahlhoff M, Andrukhova O, Grill J, Glösmann M, Schüler C, Weber K, Wolf E, Erben RG. Bone; 2012 Jan 15; 50(1):237-44. PubMed ID: 22056328 [Abstract] [Full Text] [Related]
8. Anabolic effects of PTH and the 'anabolic window'. Pazianas M. Trends Endocrinol Metab; 2015 Mar 15; 26(3):111-3. PubMed ID: 25662368 [Abstract] [Full Text] [Related]
9. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. Walker EC, Poulton IJ, McGregor NE, Ho PW, Allan EH, Quach JM, Martin TJ, Sims NA. J Bone Miner Res; 2012 Apr 15; 27(4):902-12. PubMed ID: 22190112 [Abstract] [Full Text] [Related]
10. [Biological function of bone cells on the PTH-driven anabolic effect]. Hasegawa T, Hongo H, Sasaki M, Yamada T, Amizuka N. Clin Calcium; 2012 Mar 15; 22(3):373-9. PubMed ID: 22370304 [Abstract] [Full Text] [Related]
11. Parathyroid hormone temporal effects on bone formation and resorption. Kroll MH. Bull Math Biol; 2000 Jan 15; 62(1):163-88. PubMed ID: 10824426 [Abstract] [Full Text] [Related]
13. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells. Tanaka S, Sakai A, Tanaka M, Otomo H, Okimoto N, Sakata T, Nakamura T. J Bone Miner Res; 2004 Nov 15; 19(11):1813-20. PubMed ID: 15476581 [Abstract] [Full Text] [Related]
14. Does osteocytic SOST suppression mediate PTH bone anabolism? Kramer I, Keller H, Leupin O, Kneissel M. Trends Endocrinol Metab; 2010 Apr 15; 21(4):237-44. PubMed ID: 20074973 [Abstract] [Full Text] [Related]
15. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies. Esbrit P, Alcaraz MJ. Biochem Pharmacol; 2013 May 15; 85(10):1417-23. PubMed ID: 23500550 [Abstract] [Full Text] [Related]
16. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling. Siddiqui JA, Le Henaff C, Johnson J, He Z, Rifkin DB, Partridge NC. Bone; 2021 Feb 15; 143():115762. PubMed ID: 33212319 [Abstract] [Full Text] [Related]
18. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level. Wang Y, Qin QH, Kalyanasundaram S. Mol Cell Biomech; 2009 Jun 15; 6(2):101-12. PubMed ID: 19496258 [Abstract] [Full Text] [Related]
20. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. Kuriwaka-Kido R, Kido S, Miyatani Y, Ito Y, Kondo T, Omatsu T, Dong B, Endo I, Miyamoto K, Matsumoto T. Endocrinology; 2013 Mar 15; 154(3):1156-67. PubMed ID: 23397032 [Abstract] [Full Text] [Related] Page: [Next] [New Search]